Jeffrey A Meckler insider trades
Open-market stock purchases and sales by Jeffrey A Meckler, Unknown at Travere Therapeutics, Inc, from SEC Form 4 filings since Jul 10, 2012.
Track record: 85% of 13 scored buys are up 5% or more since purchase, averaging +48%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 10, 2026 | TVTX Travere Therapeutics, Inc | Sold | $111K |
| Sep 10, 2026 | TVTX Travere Therapeutics, Inc | Sold | $79.4K |
| Sep 10, 2026 | TVTX Travere Therapeutics, Inc | Sold | $944K |
| Sep 10, 2026 | TVTX Travere Therapeutics, Inc | Sold | $211K |
| Sep 10, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 19, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 19, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Sold | $360K |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Feb 11, 2026 | INDP Indaptus Therapeutics, Inc | Sold (not open market) | $44.7K |
| Feb 11, 2026 | INDP Indaptus Therapeutics, Inc | Bought (not open market) | $2.7K |
| Feb 11, 2026 | INDP Indaptus Therapeutics, Inc | Sold (not open market) | $101K |
| Feb 11, 2026 | INDP Indaptus Therapeutics, Inc | Bought (not open market) | $21.2K |
| Feb 11, 2026 | INDP Indaptus Therapeutics, Inc | Sold (not open market) | $144K |
| Feb 11, 2026 | INDP Indaptus Therapeutics, Inc | Bought (not open market) | $5.3K |
| Dec 22, 2025 | INDP Indaptus Therapeutics, Inc | Bought (not open market) | $440K |
Companies traded
- TVTX Travere Therapeutics, Inc: 6 sales, last Sep 10, 2026
- INDP Indaptus Therapeutics, Inc: 8 buys, last Feb 11, 2026
- NTEC Intec Pharma Ltd: 2 buys, last Jul 15, 2020
- RTRX Retrophin, Inc: 3 buys, last May 15, 2020
- QLTI QLT Inc/bc: 3 buys, last Jun 17, 2016
- COCP Cocrystal Pharma, Inc: 5 buys, last Mar 15, 2016